Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 New Entrants companies in Calcium channel blocker
by Most Patent Filing In 1 Year in the world in 2019

The Calcium channel blocker top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filing In 1 Year Calcium channel blocker New Entrants in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Calcium channel blockers (CCB), calcium channel antagonists or calcium antagonists are a group of medications that disrupt the movement of calcium (Ca²⁺) through calcium channels. Calcium channel blockers are used as antihypertensive drugs, i.e., as medications to decrease blood pressure in patients with hypertension. CCBs are particularly effective against large vessel stiffness, one of the common causes of elevated systolic blood pressure in elderly patients. Calcium channel blockers are also frequently used to alter heart rate (especially from atrial fibrillation), to prevent peripheral and cerebral vasospasm, and to reduce chest pain caused by angina pectoris.
#
Company Name
Region
Tech Topics
Total
1
Shanghai Shi, China
Biology,Medicine,Health care,
...[+2]
Patent: 3
2
Washington, United States
Patent: 3
3
Tokyo, Japan
Diagnostic agent,Health care,Drug,
...[+2]
Patent: 2
4
Osaka, Japan
Patent: 2
5
Massachusetts, United States
Intracellular sodium,Health care,Inflammation,
...[+1]
Patent: 2
6
South Korea
Patent: 1
7
Shandong Sheng, China
Patent: 1
8
Daegu, South Korea
Asset management,Impact investing,Social Welfare
Patent: 1
9
Busan, South Korea
Asset management,Impact investing,Social Welfare
Patent: 1
10
CRD Pharmaceuticals Inc.
Canada
Patent: 1
Page generation time: Jun 29 2025